siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma

Mostrar otras versiones (1)

Delivery is a very important concern for therapeutic applications of siRNA. In this study, we have used chitosan-coated poly(isobutylcyanoacrylate) nanoparticles to deliver siRNA with a complementary sequence to the fusion oncogene ret/PTC1. By screening the mRNA junction we have selected a potent s...

Descripción completa

Detalles Bibliográficos
Autores principales: de Martimprey, Henri, Bertrand, Jean-Remi, Fusco, Alfredo, Santoro, Massimo, Couvreur, Patrick, Vauthier, Christine, Malvy, Claude
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Methods Online
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248757/
https://www.ncbi.nlm.nih.gov/pubmed/18079153
http://dx.doi.org/10.1093/nar/gkm1094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2248757/
https://www.ncbi.nlm.nih.gov/pubmed/18079153
http://dx.doi.org/10.1093/nar/gkm1094

Ejemplares similares